Skip to main content

Advertisement

Log in

SRS-22R Minimum Clinically Important Difference and Substantial Clinical Benefit After Adult Lumbar Scoliosis Surgery

  • Case Series
  • Published:
Spine Deformity Aims and scope Submit manuscript

Abstract

Study Design

Longitudinal cohort.

Objectives

To determine if the minimum clinically important difference (MCID) and substantial clinical benefit (SCB) thresholds for the Scoliosis Research Society—22R (SRS22R) domains in patients with degenerative lumbar scoliosis are similar to those in patients with adult spinal deformity (ASD) with fusions extending into the thoracic spine.

Summary of Background Data

The MCID and SCB thresholds for the SRS22R domains in patients with ASD and adolescent idiopathic scoliosis have been reported.

Methods

Patients enrolled in the NIH-sponsored Adult Symptomatic Lumbar Scoliosis (ASLS) trial who underwent surgery and completed the SRS22R preoperative and the SRS30 one-year postoperative were identified. One-year postoperative answers to the last eight questions of the SRS30 were used as anchors to determine the MCID and SCB for the Pain, Appearance, and Activity domains, and the Subscore and Total score using receiver operating characteristic (ROC) curve analysis.

Results

The sample population consisted of 147 patients. A total of 132 (89%) were females with a mean age of 59.4 years. There was a statistically significant improvement in all SRS22R scores from preoperative to one-year postoperative. There was also a statistically significant difference in domain scores among the different responses to the anchors. According to the ROC analysis, MCID was 1.17 for Appearance, 0.40 for Activity, 0.60 for Pain, 0.53 for Subscore, and 0.77 for Total; and SCB was 1.67 for Appearance, 0.60 for Activity, 0.62 for Subscore, and 1.11 for Total score. These are similar to previous reports of MCID and SCB thresholds for ASD patients who underwent fusion to the thoracic spine.

Conclusion

The MCID and SCB thresholds for the SRS22R domains in patients with adult symptomatic lumbar scoliosis are very similar to the threshold values previously reported for adult deformity patients.

Level of Evidence

Level II.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Asher MA, Lai SM, Glattes RC, et al. Refinement of the SRS-22 Health-Related Quality of Life questionnaire Function domain. Spine (Phila Pa 1976) 2006;31:593–7.

    Article  Google Scholar 

  2. Asher M, Min Lai S, Burton D, Manna B. Discrimination validity of the Scoliosis Research Society-22 Patient Questionnaire: relationship to idiopathic scoliosis curve pattern and curve size. Spine 2003;28:74–8.

    Article  Google Scholar 

  3. Asher M, Min Lai S, Burton D, Manna B. Scoliosis Research Society-22 Patient Questionnaire: responsiveness to change associated with surgical treatment. Spine 2003;28:70–3.

    Article  Google Scholar 

  4. Asher M, Min Lai S, Burton D, Manna B. The reliability and concurrent validity of the Scoliosis Research Society-22 Patient Questionnaire for idiopathic scoliosis. Spine 2003;28:63–9.

    Article  Google Scholar 

  5. Berven S, Deviren V, Demir-Deviren S, et al. Studies in the modified Scoliosis Research Society Outcomes Instrument in adults: validation, reliability, and discriminatory capacity. Spine (Phila Pa 1976) 2003;28:2164–9.

    Article  Google Scholar 

  6. Bridwell KH, Berven S, Glassman S, et al. Is the SRS-22 instrument responsive to change in adult scoliosis patients having primary spinal deformity surgery? Spine (Phila Pa 1976) 2007;32:2220–5.

    Article  Google Scholar 

  7. Bridwell KH, Cats-Baril W, Harrast J, et al. The validity of the SRS-22 instrument in an adult spinal deformity population compared with the Oswestry and SF-12: a study of response distribution, concurrent validity, internal consistency, and reliability. Spine (Phila Pa 1976) 2005;30:455–61.

    Article  Google Scholar 

  8. Hägg O, Fritzell P, Nordwall A. The clinical importance of changes in outcome scores after treatment for chronic low back pain. Eur Spine J 2003;12:12–20.

    Article  Google Scholar 

  9. Jaeschke R, Singer J, Guyatt GH. Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials 1989;10:407–15.

    Article  CAS  Google Scholar 

  10. Glassman SD, Copay AG, Berven SH, et al. Defining substantial clinical benefit following lumbar spine arthrodesis. J Bone Joint Surg Am 2008;90:1839–47.

    Article  Google Scholar 

  11. Crawford 3rd CH, Glassman SD, Bridwell KH, Carreon LY. The substantial clinical benefit threshold for SRS-22R domains after surgical treatment of adult spinal deformity. Spine Deform 2016;4:373–7.

    Article  Google Scholar 

  12. Crawford 3rd CH, Glassman SD, Bridwell KH, et al. The minimum clinically important difference in SRS-22R total score, appearance, activity and pain domains after surgical treatment of adult spinal deformity. Spine (Phila Pa 1976) 2015;40:377–81.

    Article  Google Scholar 

  13. Hosmer DW, Lemeshow S. Applied logistic regression. New York: Wiley, Inc; 2000.

    Book  Google Scholar 

  14. Fairbank JC, Couper J, Davies JB, et al. The oswestry low back pain questionnaire. Physiotherapy 1980;66:271–3.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Leah Y. Carreon MD, MSc.

Additional information

Author disclosures

LYC (member of the University of Louisville Institutional Review Board; research committee member of the Scoliosis Research Society; grant to institution from the National Institutes of Health; consultancy fees from the Washington University at St. Louis, AO Spine, and Norton Healthcare; Research Funding for Minimize Implants Maximize Outcomes RCT 2013—current from the Orthopedic Research and Educational Fund, paid to institution, outside the submitted work; research funding for study: Evidence-Based Algorithm for the Surgical Treatment of Lumbosacral Spondylolisthesis—current from the Scoliosis Research Society, paid to institution, outside the submitted work; annual required continuing education for institutional review board members, from the University of Louisville Institutional Review Board; travel and accommodations for Study Planning Meetings 06/2012, 02/2014, and 06/2014, from the Association for Collaborative Spine Research; travel and accommodations for Study Planning Meetings 10/2013, 05/2014, 09/2014, 12/2014, 05/2015, 08/2015, 04/2016, and 08/2016/12/2016 from the Center for Spine Surgery and Research, Region of Southern Denmark; and other from NuVasive [Nuvasive provides funds directly to database company; no funds are paid directly to Individual or Individual’s Institution 06/2012-04/2015]); MPK (grant to institution from the National Institutes of Health; grants to institution from AO Spine, Barnes Jewish Foundation, Orthopedic Research Education Foundation, and Cervical Spine Research Society, all outside the submitted work; fellowship support from AO Spine and Orthopedic Research Education Foundation, both outside the submitted work); CHC (grant to institution from the National Institutes of Health; consultancy fees from Alphatec, Medtronic, Norton Healthcare, and University of Louisville; grants to institution from the National Institutes of Health, Orthopedic Research Education Foundation, and Norton Healthcare; payment for lectures including service on speakers bureaus from DePuy Synthes; travel support from North American Spine Society and Scoliosis Research Society committee meetings; and other); CRB (grant to institution from the National Institutes of Health); SDG (grant to institution from the National Institutes of Health; employee of Norton Healthcare; patents issued for Medtronic; royalties from Medtronic; and other from NuVasive [NuVasive provides funds directly to database company; no funds are paid directly to Individual or Individual’s Institution 06/2012-04/2015]); CIS (grant to institution from the National Institutes of Health; consultancy fees from Stryker and K2M; grants to institution from the Department of Defense and the International Spine Study Group; royalties from Biomet, Medtronic, and NuVasive; stocks/stock options in NuVasive; and fellowship support from AOSpine and NREF); KHB (grant to institution from the National Institutes of Health and royalties from Wolters-Kluwer).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carreon, L.Y., Kelly, M.P., Crawford, C.H. et al. SRS-22R Minimum Clinically Important Difference and Substantial Clinical Benefit After Adult Lumbar Scoliosis Surgery. Spine Deform 6, 79–83 (2018). https://doi.org/10.1016/j.jspd.2017.05.006

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1016/j.jspd.2017.05.006

Keywords

Navigation